Saccomano Nicholas A
Insider CIK 1609284 · ARRY CSO · OKUR President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OKUR OnKure Therapeutics, Inc. | S Sale | 2026-09-21 | 2026-09-23 | 87 | $2.97 | $258 | 11,160 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | S Sale | 2026-09-21 | 2026-09-23 | 87 | $2.97 | $259 | 11,160 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 8,449 | — | $0 | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 1,485 | — | $0 | 1,485 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 1,485 | — | $0 | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 2,359 | — | $0 | 2,359 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 2,359 | — | $0 | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 150,000 | — | $0 | 150,000 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 542,232 | — | $0 | 542,232 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 542,232 | — | $0 | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 16,898 | — | $0 | 16,898 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 16,898 | — | $0 | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 8,449 | — | $0 | 8,449 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 542,232 | — | — | 542,232 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 542,232 | — | — | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 16,898 | — | — | 16,898 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 16,898 | — | — | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 8,449 | — | — | 8,449 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 8,449 | — | — | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 1,485 | — | — | 1,485 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 1,485 | — | — | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 2,359 | — | — | 2,359 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 2,359 | — | — | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 150,000 | — | $0 | 150,000 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 86 | $4.40 | $378 | 11,247 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-04-01 | 2026-04-03 | 330,000 | — | $0 | 330,000 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | S Sale | 2026-03-23 | 2026-03-24 | 86 | $4.16 | $358 | 7,333 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | S Sale | 2025-12-22 | 2025-12-23 | 87 | $2.97 | $258 | 7,419 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | S Sale | 2025-09-22 | 2025-09-24 | 88 | $2.62 | $231 | 3,506 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | S Sale | 2025-06-23 | 2025-06-25 | 88 | $2.38 | $209 | 3,594 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | S Sale | 2025-04-07 | 2025-04-08 | 516 | $2.67 | $1.4K | 3,682 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | S Sale | 2025-04-04 | 2025-04-08 | 358 | $3.33 | $1.2K | 4,198 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2025-01-27 | 2025-01-29 | 130,000 | — | $0 | 130,000 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2024-10-04 | 2024-10-08 | 2,359 | — | $0 | 2,359 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2024-10-04 | 2024-10-08 | 16,898 | — | $0 | 16,898 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2024-10-04 | 2024-10-08 | 8,449 | — | $0 | 8,449 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2024-10-04 | 2024-10-08 | 542,232 | — | $0 | 542,232 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2024-10-04 | 2024-10-08 | 1,485 | — | $0 | 1,485 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award | 2024-10-04 | 2024-10-08 | 4,556 | — | $0 | 4,556 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 168,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 131,250 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 82,500 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 165,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 138,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer | 2019-07-30 | 2019-07-30 | 150,190 | $48.00 | $7.21M | 61,813 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer | 2019-07-30 | 2019-07-30 | 61,813 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-04-01 | 2019-04-03 | 6,875 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-04-01 | 2019-04-03 | 6,875 | — | $0 | 6,875 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-04-01 | 2019-04-03 | 13,750 | — | $0 | 156,238 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2019-04-01 | 2019-04-03 | 6,048 | $24.60 | $148.8K | 150,190 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-02-07 | 2019-02-08 | 82,500 | — | $0 | 82,500 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-02-07 | 2019-02-08 | 104,764 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-02-07 | 2019-02-08 | 104,764 | $4.20 | $440.0K | 329,752 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-02-07 | 2019-02-08 | 187,264 | $21.58 | $4.04M | 142,488 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-02-07 | 2019-02-08 | 82,500 | $3.00 | $247.5K | 224,988 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-01-31 | 2019-02-04 | 95,236 | — | $0 | 104,764 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2019-01-31 | 2019-02-04 | 21,425 | $18.67 | $400.0K | 142,488 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-01-31 | 2019-02-04 | 95,236 | $4.20 | $400.0K | 163,913 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-12-16 | 2018-12-18 | 7,000 | — | $0 | 21,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-12-16 | 2018-12-18 | 5,469 | — | $0 | 10,938 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-12-16 | 2018-12-18 | 12,469 | — | $0 | 74,162 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2018-12-16 | 2018-12-18 | 5,485 | $15.97 | $87.6K | 68,677 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-12-14 | 2018-12-18 | 23,000 | — | $0 | 23,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-12-14 | 2018-12-18 | 138,000 | — | $0 | 138,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-06-27 | 2018-06-29 | 11,453 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2018-06-27 | 2018-06-29 | 5,038 | $18.50 | $93.2K | 61,693 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-06-27 | 2018-06-29 | 11,453 | — | $0 | 66,731 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-04-01 | 2018-04-03 | 6,875 | — | $0 | 13,750 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-04-01 | 2018-04-03 | 6,875 | — | $0 | 61,396 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2018-04-01 | 2018-04-03 | 6,118 | $16.32 | $99.8K | 55,278 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-12-16 | 2017-12-19 | 28,000 | — | $0 | 28,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-12-16 | 2017-12-19 | 5,468 | — | $0 | 16,407 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-12-16 | 2017-12-19 | 168,000 | — | $0 | 168,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2017-12-16 | 2017-12-19 | 2,548 | $10.92 | $27.8K | 54,521 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-12-16 | 2017-12-19 | 5,468 | — | $0 | 57,069 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-04-01 | 2017-04-04 | 6,875 | — | $0 | 20,625 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2017-04-01 | 2017-04-04 | 4,535 | $8.94 | $40.5K | 37,526 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-04-01 | 2017-04-04 | 6,875 | — | $0 | 42,061 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2017-04-01 | 2017-04-06 | 6,543 | $8.94 | $58.5K | 37,851 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-12-27 | 2016-12-29 | 21,875 | — | $0 | 21,875 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-12-27 | 2016-12-29 | 131,250 | — | $0 | 131,250 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-04-01 | 2016-04-05 | 165,000 | — | $0 | 165,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-04-01 | 2016-04-05 | 27,500 | — | $0 | 27,500 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2016-04-01 | 2016-04-05 | 2,564 | $3.00 | $7.7K | 35,186 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2015-04-01 | 2015-04-03 | 165,000 | — | $0 | 165,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award | 2015-04-01 | 2015-04-03 | 27,500 | — | $0 | 35,800 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2015-03-01 | 2015-03-04 | 11,453 | — | $0 | 11,453 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2015-03-01 | 2015-03-04 | 4,033 | $7.96 | $32.1K | 7,420 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2015-03-01 | 2015-03-04 | 11,453 | $7.96 | $91.2K | 11,453 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2014-08-18 | 2014-08-20 | 22,906 | — | $0 | 22,906 | SEC↗ |